Testing effectiveness (Phase 2)Study completedNCT01037517
What this trial is testing
Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization
Who this might be right for
Multiple MyelomaLymphoma
CancerCare Manitoba 52